Image Description (Figure 1 Zole)
Not available*
Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 68001-610
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68001-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structure (Stru Zole)
Zolderonic Acid Inj 4mg/5ml Carton (Zole Carton)
Image Description (Zole Formula)
This text appears to be a formula for calculating CrCl (creatinine clearance) in patients. The formula takes into account the age, weight, and gender of the patient, as well as the serum creatinine levels. However, due to the condition of the text obtained by , the exact values or units of measurement cannot be determined.*
Zoledronic Acid Inj 4mg/5ml (Zole Label)
This text appears to be the description and important information for a medication called Zoledronic Acid Injection. Each vial of the medication contains 4.264 mg of zoledronic acid monohydrate. The medication also includes mannitol, water for injection, and sodium citrate to adjust pH. It is crucial not to mix this medication with calcium-containing infusion solutions and it should not be directly injected. The dose must be diluted before intravenous infusion. The medication is stored at temperatures between 15°C to 30°C and should be discarded if unused. It is manufactured by Emcure Pharmaceuticals Ltd. in India for BluePoint Laboratories. The vial being described is a single-dose 5 mL vial.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
